Ever Supreme Bio Technology Co (ROCO:6712) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6712 Ever Supreme Bio Technology Co Ltd ROCO:6712
91 GF Score
Price NT$148.50
GF Value NT$191.19
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Ever Supreme Bio Technology Co FFO per Share?

FFO per Share only applies to REITs.

ROCO:6712
91GF Score
Ever Supreme Bio Technology Co Ltd ROCO:6712
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ever Supreme Bio Technology Co (ROCO:6712) Overvalued in 2026?

Based on GuruFocus' analysis, Ever Supreme Bio Technology Co stock appears to be undervalued. The current stock price of NT$148.50 is trading 22.3% below its estimated GF Value™ of NT$191.19. GuruFocus considers Ever Supreme Bio Technology Co to be Modestly Undervalued.

Key valuation signals for ROCO:6712:

  • FFO per Share:
  • GF Value™: NT$191.19 vs. price of NT$148.50 (22.3% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6712 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ever Supreme Bio Technology Co Business Description

Address Keya Road, 4th Floor, No. 30, Daya District, Taichung, TWN
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the Cell Preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.
91GF Score

Get the complete analysis for ROCO:6712

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$148.50
Price
NT$191.19
GF Value